Thus, the anti-Spike antibodies induced upon infection by WA1 strain showed robust cross-reactivity among the panel of Spike-RBD tested and they maintain a similar ranking in recognition of variant Spike-RBD at early (2 months) and late (14 months) time points post symptom onset. This evidence concerns the gene CHMP5 and infection.